1 study found for:
15937070 [PUBMED-IDS]
Create an RSS feed from your search for:
Download the search results for:| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
|
† Indicates status has not been verified in more than two years